Dɛn dɔn gi yu di mɛrɛsin we dɛn kɔl Elotuzumab fɔ yu Multiple Myeloma kansa? Ɔ pɔsin we de nia yu de kam fɔ bigin dis tritmɛnt? Na nɔmal tin fɔ fil smɔl frayd ɛn fred we yu yɛri nem lɛk dis. Bɔt we yu no gud gud wan us kayn drɔg dis na, wetin i de du, ɛn wetin yu nid fɔ tek tɛm wit, da fred de nɔ de igen. So tide, lɛ wi tɔk bɔt dis drɔg Elotuzumab insay wan rili simpul we, insay wan we we yu go ɔndastand.
Us kayn mɛrɛsin na Elotuzumab?
Fɔ tɔk am simpul wan, Elotuzumab na spɛshal mɛrɛsin we de tɔch ɛn atak di kansa sɛl dɛn. i de pan wan klas dεm we dεn kכl ``Monoclonal Antibody.'' Imajin se wi bכdi in imyun sistεm gεt sojaman dεm, we wi kכl antibodi. Dɛn tin ya kin mek dɛn no ɛn pwɛl di jem ɛn vayrɔs dɛn we kin mek pɔsin gɛt sik.
naw, dis `(Monoclonal Antibody)` min se dεn de mek antibodi dεm artifishal wan na di labכtכri. Bɔt dɛn mek dɛn tin ya fɔ spɛshal rizin. Dat min se fɔ no wan patikyula prɔtin (antijen) we de na di kansa sɛl dɛn, fɔ atak dɛn kansa sɛl dɛn de nɔmɔ, ɛn ɛp wi yon bɔdi in imyun sistɛm fɔ pwɛl dɛn. Jɔs lɛk aw ki kin opin lɔk, dis mɛrɛsin kin go dairekt fɔ fɛn di kansa sɛl dɛn.
Dɛn kin yuz dis mɛrɛsin mɔ fɔ mɛn multiple myeloma , we na wan kayn kansa we kin afɛkt di plasma sɛl dɛn we de na di blɔd. Sɔntɛnde, yu dɔktɔ kin gi am bak fɔ ɔda sik dɛn. So if yu gɛt ɛni kwɛstyɔn bɔt wetin mek dɛn de gi yu dis mɛrɛsin, aks yu dɔktɔ.
Tin dɛm wae yu fɔ tɛl yu dɔktɔ bifo yu bigin tritmɛnt
Bifo yu bigin dis tritmɛnt, i rili impɔtant fɔ mek yu dɔktɔ gɛt kɔmplit pikchɔ bɔt yu wɛlbɔdi. So if yu gɛt ɛni wan pan dɛn tin ya, mek shɔ se yu tɛl yu dɔktɔ.
- If yu gɛt ɛni liva sik: Di liva na di men ɔgan na wi bɔdi we de mɛtabolayz mɛrɛsin. So, if yu gɛt ɛni liva we nɔ de wok fayn, yu kin nid fɔ chenj di mɛrɛsin we yu de tek ɔ tek spɛshal kia.
- If yu gɛt infɛkshɔn we dɔn de: fiva, kɔf, kol, urinary tract infection, ɛn ɔda tin dɛn Dis na bikɔs dis tritmɛnt kin afɛkt di imyun sistɛm, we kin mek di infɛkshɔn we dɔn de, wɔs.
- If yu dɔn ɛva gɛt alɛji fɔ dis mɛrɛsin ɔ ɛni ɔda mɛrɛsin, it, ɔ day: Dis rili impɔtant bikɔs sɔm pipul dɛn kin gɛt alɛji fɔ dis mɛrɛsin.
- If yu gɛt bɛlɛ, yu de tray fɔ gɛt bɛlɛ, ɔ yu de gi pikin in bɛlɛ:Dis tritmɛnt kin afɛkt di pikin we de na di bɛlɛ, so i impɔtant fɔ tɛl di dɔktɔ bɔt dis.
Aw a go gi yu dis mɛrɛsin?
Elotuzumab nɔto pil we yu de swɛla. Na mɛrɛsin we dɛn kin gi insay wan vein (wan `infusion`) lɛk salin . Dɛn kin gi dis tritmɛnt na ɔspitul ɔ klinik bay trenin mɛdikal wokman dɛm.
De tritmɛnt kin tek wan awa ɔr mɔr fɔ gi. Insay dis tɛm, nɔs ɔ dɔktɔ go de wach yu ɔltɛm.
De tin wae impɔtant pas ɔl na fɔ gɛt yu tritmɛnt pan tɛm , pan di de dɛm wae yu dɔktɔ gi yu. Nɔ mis tritmɛnt sɛshɔn fɔ ɛni rizin. If yu nɔ ebul fɔ atɛnd, kɔl yu dɔktɔ wantɛm wantɛm ɛn mek dɛn no.
Wetin fɔ du if di doz go ɔp?
Dɛn kin gi dis na ɔspitul, so di chans fɔ mek dis apin rili smɔl. Bɔt if yu tink se yu go dɔn tek di mɛrɛsin pasmak , tɛl di wan dɛn we de wok de wantɛm wantɛm. Ɔ kɔl di Nashɔnal Pɔyzin Infɔmeshɔn Sɛnta na di Kɔlɔmbɔ Nashɔnal Ospital . If ɛnitin apin, go na di Imejɛnsi Tritmɛnt Yunit (ETU) we de nia yu .
Tin dɛn we yu fɔ tink bɔt we yu de du tritmɛnt
- Alɛji: Sɔm pipul dɛn kin gɛt alɛji fɔ dis mɛrɛsin. Fɔ ridyus dis risk, yu dɔktɔ kin disayd fɔ gi yu ɔda mɛrɛsin (e.g., piridine, steroid) bifo i gi yu elotuzumab. So tek di mɛrɛsin dɛn jɔs lɛk aw dɛn tɛl yu fɔ tek.
- Blɔd Tɛst: We yu de du di tritmɛnt, yu go nid fɔ du blɔd tɛst ɔltɛm fɔ si aw di mɛrɛsin de afɛkt yu bɔdi ɛn fɔ chɛk fɔ sayd ɛfɛkt.
- Bεlε εn bεlε: Nɔ bεlε we yu de trit yu. Dis mɛrɛsin kin ambɔg pikin we nɔ bɔn yet. Dɔn bak, nɔ fɔ gi pikin in bɛlɛ we yu de trit yu ɛn fɔ sɔm tɛm afta yu dɔn stɔp di tritmɛnt. Aks yu dɔktɔ fɔ no mɔ bɔt dis.
- Ɔda mɛrɛsin dɛn: Tɛl yu dɔktɔ bɔt ɛni ɔda mɛrɛsin (fɔ ɔda kɔndishɔn), ɔyl, vaytamɛn, ɛn it we yu de tek, bikɔs sɔm kin miks wit dis mɛrɛsin.
- Kansa risk: Na smɔl risk de fɔ gɛt sɔm ɔda kayn kansa wae yu de gɛt dis kayn tritmɛnt. Nɔ mek dis fred, bɔt tɔk to yu dɔktɔ opin ɛn ɔnɛs bɔt am.
Wetin na di bad tin dɛn we kin apin to pɔsin?
Lɛk ɛni mɛrɛsin, Elotuzumab kin mek yu gɛt sayd ɛfɛkt. Bɔt, nɔto ɔlman kin gɛt dɛn. Lɛ wi lan mɔ bɔt dɛn na di tebul we de dɔŋ ya.
| Sayd ɛfɛkt we pɔsin kin gɛt | Diskripshɔn ɛn wetin yu nid fɔ du |
|---|---|
| Siriɔs sayd ɛfɛkt dɛm we yu fɔ ripɔt to yu dɔktɔ ɔr nɔs wokman dɛm wantɛm wantɛm | |
| Sivɛri Alɛji Riakshɔn | Skin rash, it, swel na yu fes, lip, tong, i nɔ izi fɔ blo, yu chɛst tayt. (Dis na imejensi) |
| Sayn dɛn we de sho se pɔsin gɛt di sik | Fiva, kol, trot we de at, kɔf, ɛn pen we yu de pis. |
| Simptom dɛm fɔ Liva Injury | di yay ɔ di skin we de yɔlɔ, di urine we de dak yɔlɔ ɔ brawn, di stɔl we de shayn, pen na di ɔp rayt say na di bɛlɛ, yu nɔ de fil fayn, yu nɔ de want fɔ it, yu taya pasmak. |
| Di sayn dɛn we de sho se yu gɛt bɔku blɔd shuga | Mɔt dray, tɔsti pasmak , pis bɔku tɛm, angri pasmak, ɛn frut briz smɛl. |
| Ɔda bad bad sayn dɛn | Chɛst pen, diziz, ɛn fil lɛk se yu ed layt. |
| Sayd ɛfɛkt dɛn we nɔ kin siriɔs, bɔt dɛn fɔ ripɔt to di dɔktɔ if dɛn kɔntinyu fɔ de | |
| Prɔblɛm dɛn we de na di dijestiv sistɛm | Kɔnstipɛshɔn, dayarɛa, nɔ want fɔ it. |
| Prɔblɛm dɛn we gɛt fɔ du wit di nerve | Di an ɛn fut dɛn kin swɛla, i kin fil pen, ɔ i nɔ kin fil fayn. |
| We pɔsin taya | Taya pasmak ɛn taya na di bɔdi. |
If yu gɛt ɛni ɔda kayn sik we nɔ kɔmɔn we dɛn nɔ tɔk bɔt na dis list, duya tɛl yu dɔktɔ bɔt dɛn bak.
Mɛsej we dɛn kin kɛr go na os
- Elotuzumab na wan patikyula tritmɛnt fɔ Multiple Myeloma kansa we de tɔch ɛn pwɛl kansa sɛl dɛn.
- Bifo yu bigin fɔ trit yu, mek shɔ se yu tɛl yu dɔktɔ bɔt ɔl yu mɛrɛsin ɛn ɔda mɛrɛsin dɛn we yu de tek.
- Dɛn kin gi dis mɛrɛsin tru wan vein na ɔspitul. I rili impɔtant fɔ gɛt tritmɛnt pan di de dɛn we dɛn dɔn tɛl yu fɔ du.
- Yu fɔ de wach fɔ sayn dɛm fɔ siriɔs alɛji, sayn dɛm fɔ infekshɔn, ɛn sayn dɛm fɔ se yu liva dɔn pwɛl. If yu gɛt ɛnitin we de mɔna yu, tɛl yu dɔktɔ wantɛm wantɛm.
- Nɔ gɛt bɛlɛ ɛn gi pikin in bɛlɛ we yu de trit yu.
- Na yu rayt fɔ tɔk to yu dɔktɔ opin wan bɔt ɛni kwɛstyɔn ɔ tin we de mɔna yu.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt